In vitro neuroprotective potentials of aqueous and methanol extracts from Heinsia crinita leaves

Food Science and Human Wellness

Volumn 5, Issue 2, 2016, Pages 95-102

  Oboh, Ganiyu ^a   Nwanna, Esther E ^a   Oyeleye, Sunday I ^a   Olasehinde, Tosin A ^b   Ogunsuyi, Opeyemi B ^a   Boligon, Aline A ^c  

^a FEDERAL UNIVERSITY OF TECHNOLOGY   (Nigeria)

^b Federal Institute of Industrial Research Oshodi (FIIRO)   (Nigeria)

^c FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

Author keywords

Heinsia crinita; Malondialdehyde; Neurodegeneration; Oxidative stress; Polyphenols

Indexed keywords

EID: 85068996638     PISSN: None     EISSN: 22134530     Source Type: Journal    
DOI: 10.1016/j.fshw.2016.03.001     Document Type: Article

References (51)

1. Marksberry, W.R., Lovell, M.A., Damage to lipids, proteins, DNA and RNA in mild cognitive impairment. Arch. Neurol. 64 (2007), 954–956.
2. Oboh, G., Rocha, J.B.T., Distribution and antioxidant activity of polyphenols in ripe and unripe tree pepper (Capsicum pubescens). J. Food Biochem. 31 (2007), 456–473.
3. Uttara, B., Singh, A.V., Zamboni, P., Mahajan, R.T., Oxidative stress and neurodegenerative diseases: a review of upstream and downstream antioxidant therapeutic options. Clin. Neuropharmacol. 7 (2009), 65–74.
4. Thomas, T., Monoamine oxidase-B inhibitors in the treatment of Alzheimers disease. Neurobiol. Aging 21 (2000), 343–348.
5. Baker, G.B., Matveychuk, D., MacKenzie, E.M., Dursun, S.M., Mousseau, D.D., Monoamine oxidase inhibitors and neuroprotective mechanisms. Bull. Clin. Psychopharmacol. 22 (2012), 293–296.
6. +-ATPase activity in aging and disease. Int. J. Biomed. Sci., 10(2), 2014, 85.
7. +-ATPase and acetylcholinesterase activities induced by amyloid-b peptide in rat brain and GML ganglioside neuroprotective action. Neurochem. Res. 38 (2013), 2342–2350.
8. Lees, L.G., Inhibition of sodium-potassium-ATPase: a potentially ubiquitous mechanism contributing to central nervous system neuropathology. Brain Res. Rev. 16 (1991), 283–300.
9. Mukherjee, P.K., Kumar, V., Mal, M., Houghton, P.J., Acetylcholinesterase inhibitors from plants. Phytomedicine 14 (2007), 289–300.
10. +-ATPase, a potent neuroprotective modulator against Alzheimer disease. Fundam. Clin. Pharmacol. 27 (2013), 96–103.
11. Vladimir-Kneevic, S., Blaekovic, B., Kindl, M., Vladic, J., Lower-Nedza, A.D., Brantner, A.H., Acetylcholinesterase inhibitory, antioxidant and phytochemical properties of selected medicinal plants of the Lamiaceae family. Molecules 19 (2004), 767–782.
12. Ebong, P.E., Igile, G.O., Mgbeje, B.I., Iwara, I.A., Odongo, A.E., Onofiok, U.L., Oso, E.A., Hypoglycemic, hepatoprotective and nephroprotective effects of methanolic leaf extract of Heinsia crinita (Rubiaceae) in alloxan-induced diabetic albino wistar rats. IOSR J. Pharm. 4 (2014), 37–43.
13. Enyi-idoh, K.H., Ikpeme, E.M., Iwuh, G.C., Antibacterial activity of Gnetum africanum and Heinsia crinita on diarrhoeagenic bacteria stool isolates from children in Calabar south LGA, Cross river state, Nigeria. Transnatl. J. Sci. Technol. 3 (2012), 28–36.
14. Singleton, V.L., Orthofer, R., Lamuela-Raventos, R.M., Analysis of total phenols and other oxidation substrates and antioxidants by means of Folin–Ciocalteau's reagent. Methods Enzymol. 299 (1999), 152–178.
15. Meda, A., Lamien, C., Romito, M., Millogo, J., Nacoulma, O.G., Determination of the total phenolic, flavonoid and proline contents in Burkina Faso honey, as well as their radical scavenging activity. Food Chem. 91 (2005), 571–577.
16. Adedayo, B.C., Oboh, G., Oyeleye, S.I., Ejakpovi, I.I., Boligon, A.A., Athayde, M.L., Blanching alters the phenolic constituents and in vitro antioxidant and anticholinesterases properties of fireweed (Crassocephalum crepidioides). J. Taibah Univ. Med. Sci. 10 (2015), 419–426.
17. Nwanna, E.E., Oyeleye, S.I., Ogunsuyi, O.B., Oboh, G., Boligon, A.A., Athayde, M.L., In vitro neuroprotective properties of some commonly consumed green leafy vegetables in Southern Nigeria. NFS J. 2 (2016), 19–24.
18. Public Health Service (PHS), Public Health Service Policy on Humane Care and Use of Laboratory Animals (PL 99-158. Health Research Extension Act, 1985). 1996, US Department of Health and Human Services, Washington, DC.
19. Belle, N., Dalmolin, G., Fonini, G., Polyamines reduce lipid peroxidation induced by different pro-oxidant agents. Brain Res. 1008 (2004), 245–251.
20. Ohkawa, H., Ohishi, N., Yagi, K., Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 95 (1979), 351–358.
21. Green, A.L., Haughton, T.M., A colorimetric method for the estimation of monoamine oxidase. Biochem. J. 78:1961 (1961), 172–176.
22. Turski, W., Turska, E., Bellard, G.M., Modification of the spectrophotometric method of the determination of monoamine oxidase. Vopr. Med. Khim. 14 (1973), 211–220.
23. +-ATPase activity after brain ischemia. Neurochem. Res. 25 (2000), 969–973.
24. Fiske, C.H., Subbarow, Y., The colorimetric determination of phosphorous. J. Biol. Chem. 66 (1925), 375–400.
25. Perry, N.S., Houghton, P.J., Theobald, A., Jenner, P., Perry, E.K., In-vitro inhibition of human erythrocyte acetylcholinesterase by Salvia lavandulaefolia essential oil and constituent terpenes. J. Pharm. Pharmacol. 52 (2000), 895–902.
26. Ellman, G.L., Courtney, K.D., Andres, V., Featherstone, R.M., A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 7 (1961), 88–95.
27. Butterfield, D.A., Castegna, A., Pocernich, C.B., Drake, J., Scapagnini, G., Calabrese, V., Nutritional approaches to combat oxidative stress in Alzheimer's disease. J. Nutr. Biochem. 13 (2002), 444–461.
28. Martinez, G.R., Loureiro, A.P., Marques, S.A., Miyamoto, S., Yamaguchi, L.F., Onuki, J., et al. Oxidative and alkylating damage in DNA. Mutat. Res. 544 (2003), 115–127.
29. Zhao, Y., Dou, J., Wu, T., Aisa, H.A., Investigating the antioxidant and acetylcholinesterase inhibition activities of Gossypium herbaceam. Molecules 18:1 (2013), 951–962.
30. Olfsson, J., Adolfsson, R., Gottfries, C.G., Roos, B.E., Changes in the brain catecholamines in patients with dementia of Alzheimer type. Br. J. Psychiatry 135 (1979), 216–223.
31. Bayır, H., Kochanek, P.M., Kagan, V.E., Oxidative stress in immature brain after traumatic brain injury. Dev. Neurosci. 28 (2006), 420–431.
32. Benamar, H., Rached, W., Derdour, A., Marouf, A., Screening of Algerian medicinal plants for acetylcholinesterase inhibitory activity. J. Biol. Sci. 10 (2010), 1–9.
33. +-ATPase glutathione-S-transferase and multiple unit activity and reduces lipid peroxidation and lipofuscin concentration in aged rat brain regions. Neurosci. Lett. 301 (2001), 1–4.
34. +-ATPase activity and reduces lipofuscin accumulation in discrete brain regions of aged rats. Ann. N. Y. Acad. Sci. 1019 (2004), 350–354.
35. Lees, A.J., Dopamine agonists in Parkinson's disease: a look at apomorphine. Fundam. Clin. Pharmacol. 7 (1993), 121–128.
36. +-ATPase activity in rat hippocampus. Physiol. Behav. 80 (2004), 475–479.
37. Subash, S., Essa, M.M., Al-Asmi, A., Vaishnav, S.A., Braidy, N., Manivasagam, T., et al. Pomegranate from Oman alleviates the brain oxidative damage in transgenic mouse model of Alzheimer's disease. J. Tradit. Compl. Med. 4 (2014), 232–238.
38. +-ATPase during the restoration of normotension after experimentally induced hypertension in rats. Exp. Physiol. 88 (2003), 475–482.
39. Miao, G., Zhao, H., Guo, K., Cheng, J., Zhang, X., Cai, Z., et al. Mechanisms underlying attenuation of apoptosis of cortical neurons in the hypoxic brain by flavonoids from the stems and leaves of Scutellaria baicalensis Georgi. Neural Regen. Res. 9 (2014), 1592–1598.
40. 2+-ATPase by activated oxygen through thiol- and lipid-dependent mechanisms. Biochim. Biophys. Acta 862 (1986), 8–16.
41. Cohadon, F., Rigoulet, M., Guerin, B., Vandendriessche, M., Vasogenic cerebral oedema. Changes in membrane ATPases. Correction by a phospholipid precursor. Nouv. Presse Med. 8 (1979), 1589–1591.
42. Čolović, B.M., Krstić, D.Z., Lazarević-Pašti, T.D., Bondžić, A.M., Vasić, V.M., Acetylcholinesterase inhibitors: pharmacology and toxicology. Curr. Neuropharmacol. 11 (2013), 315–335.
43. Oboh, G., Bakare, O.O., Ademosun, A.O., Akinyemi, A.J., Olasehinde, T.A., Inhibition of cholinesterases and some pro-oxidant induced oxidative stress in rats brain by two tomato (Lycopersicon esculentum) varieties. Int. J. Biomed. Sci., 11, 2015, 48.
44. Lane, L.M., Potkin, S.G., Enz, A., Targeting acetylcholinesterase and butyrylcholinesterase in dementia. Int. J. Neuropsychopharmacol. 9 (2006), 101–124.
45. Fernandez-Bachiller, M.I., Perez, C.P., Monjas, L., Rade-mann, J., Rodríguez-Franco, M.I., New tacrine-4-oxo-4H-chromene hybrids as multifunctional agents for the treatment of Alzheimer's disease, with cholinergic, antioxidant, and β-amyloid-reducing properties. J. Med. Chem. 55 (2012), 1303–1317.
46. Ademosun, A.O., Oboh, G., Olupona, A.J., Oyeleye, S.I., Adewuni, T.M., Nwanna, E.E., Comparative study of chemical composition, in vitro inhibition of cholinergic and monoaminergic enzymes, and antioxidant potentials of essential oil from peels and seeds of sweet orange (Citrus sinensis [L.] Osbeck) fruits. J. Food Biochem., 2015, 10.1111/jfbc.12187.
47. Mankil, J., Moonsoo, P., Acetylcholinesterase inhibition by flavonoids from Agrimonia pilosa. Molecules 12 (2007), 2130–2139.
48. Roseiroa, L.B., Rauter, A.P.B., Serralheiro, M.L.M., Polyphenols as acetylcholinesterase inhibitors: structural specificity and impact on human disease. Nutr. Aging 1 (2012), 99–111.
49. Xie, Y., Yang, W., Chen, X., Xiao, J., Inhibition of flavonoids on acetylcholine esterase: binding and structure–activity relationship. Food Funct. 5 (2014), 2582–2589.
50. Vauzour, D., Dietary polyphenols as modulators of brain functions. Biological actions and molecular mechanisms underpinning their beneficial effects. Oxid. Med. Cell Longev., 2012, 10.1155/2012/914273.
51. Slemmer, J.E., Weber, J.T., Assessing antioxidant capacity in brain tissue: methodologies and limitations in neuroprotective strategies. Antioxidants 3:4 (2014), 636–648.